Skip to content

Study · Case report or series · n = 2 · 1998

1 result

Ventricular tachycardia after oxytocin injection in patients with prolonged Q-T interval syndrome--report of two cases.

Liou SC, Chen C, Wong SY, Wong KM

Acta anaesthesiologica Sinica1 Mar 1998Cited by 16 (Europe PMC)

PMID9807850 (opens in a new tab)PepBankPUB-09807850
Publisher pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanCase report or seriesSafety outcome

    In two patients suspected to have prolonged Q-T interval syndrome, ventricular tachycardia developed immediately after intravenous oxytocin injection.

    In plain wordsIn two patients suspected to have a heart rhythm condition, a dangerous fast heart rhythm started right after an oxytocin injection into a vein.

    Peptide
    Oxytocin
    Outcome
    IncreaseVentricular tachycardia after intravenous oxytocin
    Study

    n = 2

    Outcome group
    Adverse events · Cardiovascular
    Studied dose
    Dose not stated · intravenousAs given in this study (human).

    Source sentences

    Summary
    We reported two cases suspected to have preexisting prolonged Q-T interval syndrome (PQTS) who developed ventricular tachycardia immediately after intravenous injection of oxytocin.
    1 context sentence
    Summary · context
    Oxytocin is widely used in obstetric settings to stimulate uterine contraction and prevent postpartum hemorrhage.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Registered trials1

Trials this study reports on, or that list this study as a reference. Registry data from ClinicalTrials.gov.

1 trial · 1 completed · 1 with posted results · source ClinicalTrials.gov (opens in a new tab)

CompletedEarly phase 1Results postedNCT01780337

Oxytocin Effects on Cardiac Electrophysiology

William Whangn = 12Jan 2013 to May 2016

Cardiac Arrhythmia

Trial pageClinicalTrials.govUpdated 21 Jul 2016

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:51 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.